tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Gil Blum, 371 are a BUY (97.38%), 7 are a HOLD (1.84%), 3 are a SELL (0.79%).
Analyst Gil Blum, currently employed at NEEDHAM, carries an average stock price target met ratio of 25.92% that have a potential upside of 62.81% achieved within 147 days. Previously, Gil Blum worked at TRUIST.
Gil Blum’s has documented 726 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRPT, Sarepta Therapeutics at 29-Jul-2025.
Analyst best performing recommendations are on CTIC (CTI BIOPHARMA CORP).
The best stock recommendation documented was for CELC (CELCUITY LLC) at 6/30/2025. The price target of $29 was fulfilled within 28 days with a profit of $15.65 (117.23%) receiving and performance score of 41.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$0.6 (42.86%)
1 years 7 months 24 days ago
(18-Dec-2023)
0/2 (0%)
$0.7 (53.85%)
Buy
$2
$0.6 (42.86%)
$36
2 years 29 days ago
(13-Jul-2023)
0/2 (0%)
$0.59 (41.84%)
Hold
$2
$0.6 (42.86%)
$2
2 years 30 days ago
(12-Jul-2023)
1/3 (33.33%)
$0.57 (39.86%)
7
Buy
2 years 8 months 4 days ago
(07-Dec-2022)
0/2 (0%)
$13.44 (140.59%)
Buy
3 years 2 months 25 days ago
(17-May-2022)
0/1 (0%)
$19.05 (212.85%)
Which stock is Gil Blum is most bullish on?
Which stock is Gil Blum is most reserved on?
What Year was the first public recommendation made by Gil Blum?
